Essilor, HPO enter exclusive global license agreement

Article

Charenton le Pont, France-Essilor has signed an exclusive and global license agreement with High Performance Optics (HPO), that complements its existing patent and technologies portfolio. This license agreement will allow Essilor to continue to focus on products with correction and preventive benefits and to roll out its portfolio of products around the world.

The pact enables Essilor to strengthen its mission of reaching the 4.2 billion people worldwide who need vision correction.

As a result of the company’s R&D and innovation processes, Essilor currently has approximately 5,600 patents throughout the world that help extend its strategy.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
2 experts in this video
2 experts in this video
Dan Ignaszewski, executive director of the Alliance for Eye and Vision Research and the National Alliance for Eye and Vision Research, provides insight into the new campaign and how to get involved.
© 2025 MJH Life Sciences

All rights reserved.